ES504922A0 - Procedimiento para la preparacion de acidos oxirancarboxili-cos sustituidos con fen(alc)oxi - Google Patents

Procedimiento para la preparacion de acidos oxirancarboxili-cos sustituidos con fen(alc)oxi

Info

Publication number
ES504922A0
ES504922A0 ES504922A ES504922A ES504922A0 ES 504922 A0 ES504922 A0 ES 504922A0 ES 504922 A ES504922 A ES 504922A ES 504922 A ES504922 A ES 504922A ES 504922 A0 ES504922 A0 ES 504922A0
Authority
ES
Spain
Prior art keywords
oxi
alc
fen
oxy
carboxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES504922A
Other languages
English (en)
Other versions
ES8300730A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of ES8300730A1 publication Critical patent/ES8300730A1/es
Publication of ES504922A0 publication Critical patent/ES504922A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/178Unsaturated ethers containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/257Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings
    • C07C43/29Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings containing halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES504922A 1980-08-25 1981-08-24 Procedimiento para la preparacion de acidos oxirancarboxili-cos sustituidos con fen(alc)oxi Granted ES504922A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH639780 1980-08-25
CH152681 1981-03-06

Publications (2)

Publication Number Publication Date
ES8300730A1 ES8300730A1 (es) 1982-11-16
ES504922A0 true ES504922A0 (es) 1982-11-16

Family

ID=25687902

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504922A Granted ES504922A0 (es) 1980-08-25 1981-08-24 Procedimiento para la preparacion de acidos oxirancarboxili-cos sustituidos con fen(alc)oxi

Country Status (16)

Country Link
US (1) US4337267A (es)
EP (1) EP0046590B1 (es)
JP (1) JPS6059914B2 (es)
AU (1) AU549447B2 (es)
CA (1) CA1167050A (es)
DE (1) DE3170608D1 (es)
DK (1) DK171890B1 (es)
ES (1) ES504922A0 (es)
GR (1) GR75741B (es)
IE (1) IE51534B1 (es)
IL (1) IL63627A (es)
NZ (1) NZ198136A (es)
PH (1) PH21847A (es)
PT (1) PT73563B (es)
WO (1) WO1982000643A1 (es)
YU (1) YU206681A (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680507D1 (de) * 1985-08-02 1991-08-29 Byk Gulden Lomberg Chem Fab Verwendung von oxirancarbonsaeuren zur behandlung der hyperlipaemie.
GB2202222B (en) * 1987-03-16 1991-03-27 American Home Prod Fluorooxirane carboxylates
US4788304A (en) * 1987-12-07 1988-11-29 American Home Products Corporation Phospholipase A2 inhibitors
DE3906953A1 (de) * 1989-03-04 1990-09-20 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung optisch reiner oxirancarbonsaeuren
US5545672A (en) * 1993-02-11 1996-08-13 The University Of Texas System Treatment of insulin resistance and type 2 diabetes mellitus with a thiol protease inhibitor
IS4164A (is) * 1993-06-11 1994-12-12 Ab Astra Efnasambönd sem hindra flæði magasýru
US5556863A (en) * 1993-06-11 1996-09-17 Astra Aktiebolag Compound for gastric acid secretion inhibition
AU3464397A (en) * 1996-07-02 1998-01-21 Sang Sup Jew Oxirane carboxylic acid derivative and its manufacturing method
KR19980028082A (ko) * 1996-10-21 1998-07-15 김박광 혈당 강하 작용을 갖는 신규 옥시란 카복실산의 유도체, 그 제조방법 및 이를 함유하는 당뇨병 치료제
DE19705718A1 (de) 1997-02-14 1998-08-20 Horst P O Dr Wolf Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände
US5932763A (en) * 1997-05-15 1999-08-03 Bayer Corporation Inhibition of matrix metalloproteases by 2-(ω-arolalkyl)-4-biaryl-4-oxobutyric acids
DE10115938A1 (de) * 2001-03-30 2002-10-10 Medigene Ag Ges Fuer Molekular Verfahren zur Herstellung von Oxirancarbonsäuren und Derivaten davon
WO2003026582A2 (en) * 2001-09-26 2003-04-03 Emisphere Technologies Inc. Method of preparing phenoxy alkanoic, alkenoic, and alkynoic acids and salts thereof via a dicarboxylate intermediate
AU2004212004B2 (en) * 2003-02-13 2008-01-10 Albert Einstein College Of Medicine Of Yeshiva University Regulation of food intake and glucose production by modulation of long-chain fatty acyl-coa levels in the hypothalamus
WO2006041922A2 (en) * 2004-10-08 2006-04-20 Dara Biosciences, Inc. Agents and methods for administration to the central nervous system
WO2006088875A2 (en) * 2005-02-14 2006-08-24 Albert Einstein College Of Medicine Of Yeshiva University Intranasal administration of modulators of hypothalamic atp-sensitive potassium channels
CA2766282C (en) * 2008-06-27 2021-03-02 Meta-Iq Aps Inhibitors of carnitin-palmitoyl-transferase-1 for the treatment and prevention of disorders caused by delipidation of neural tissue
EP3307262B1 (en) 2015-06-15 2021-05-19 NMD Pharma A/S Compounds for use in treating neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1551078A (en) * 1975-09-22 1979-08-22 Mcneilab Inc Alkyl-substituted glycidates and thioglycidates
US4196300A (en) * 1975-09-22 1980-04-01 Mcneilabs, Inc. α-Alkyl-substituted glycidates and thioglycidates
US4132720A (en) * 1978-04-20 1979-01-02 Mcneil Laboratories, Inc. Alkenylglycidic acid derivatives
US4132719A (en) * 1978-04-20 1979-01-02 Mcneilab Inc. Dibromoalkylglycidic acid derivatives
ATE3291T1 (de) * 1979-09-07 1983-05-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituierte oxirancarbonsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel.

Also Published As

Publication number Publication date
AU7447581A (en) 1982-03-04
WO1982000643A1 (en) 1982-03-04
IL63627A0 (en) 1981-11-30
ES8300730A1 (es) 1982-11-16
IE51534B1 (en) 1987-01-07
IL63627A (en) 1984-11-30
PH21847A (en) 1988-03-17
PT73563B (en) 1983-07-14
AU549447B2 (en) 1986-01-30
JPS6059914B2 (ja) 1985-12-27
DE3170608D1 (en) 1985-06-27
CA1167050A (en) 1984-05-08
EP0046590A2 (de) 1982-03-03
EP0046590A3 (en) 1982-04-07
IE811931L (en) 1982-02-25
NZ198136A (en) 1983-12-16
EP0046590B1 (de) 1985-05-22
JPS57501233A (es) 1982-07-15
YU206681A (en) 1983-10-31
US4337267A (en) 1982-06-29
DK183882A (da) 1982-04-23
PT73563A (en) 1981-09-01
GR75741B (es) 1984-08-02
DK171890B1 (da) 1997-08-04

Similar Documents

Publication Publication Date Title
ES504922A0 (es) Procedimiento para la preparacion de acidos oxirancarboxili-cos sustituidos con fen(alc)oxi
ES505959A0 (es) Procedimiento para la preparacion de un inactivador de alfa-amilasa
MX6869E (es) Procedimiento para la preparacion de dibenzimidiazoazepinas
ES499103A0 (es) Procedimiento para la determinacion de glicerina
ES507667A0 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
AR226202A1 (es) Procedimiento para la preparacion de 7-acil-3-yodometil-cefalosporinas
MX160977A (es) Procedimiento para la preparacion de cloroformiatos alfa-clorados
IT1170850B (it) Procedimento per la orot-sostituzione di fenoli
ES524806A0 (es) Procedimiento para la preparacion de ramnosa o fucosa
MX159635A (es) Procedimiento para la preparacion de peroxidos organicos
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
MX6305E (es) Procedimiento para la preparacion de 3-0(beta-d-glucouronopiranosil)-soyasapogenol b
ES507468A0 (es) Procedimiento para la preparacion de acilureas.
ES503975A0 (es) Procedimiento para la preparacion de nuevas fenilureas
ES502120A0 (es) Procedimiento para la preparacion de compuestos de viniles- tilbeno
ES505403A0 (es) Procedimiento para la determinacion de glicerina
ES500068A0 (es) Procedimiento para la obtencion de nuevos tioles
ES500071A0 (es) Procedimiento para la preparacion de nuevos 2-nitro-5-feno- xifenil-oxazoles,-oxacinas,-imidazoles,-pirimidinas o-tiazo-les
AR229350A1 (es) Procedimiento para la preparacion de nuevas guanilamidinas
ES505095A0 (es) Procedimiento para la preparacion de nuevas pirazinas
ES500267A0 (es) Procedimiento para la obtencion de compuestos de isotiazoli-lo
ES499209A0 (es) Procedimiento para la preparacion de 3-desoxi-a15-esteroides
ES505324A0 (es) Procedimiento para la preparacion de 4-carbamoiloxi-oxaza- fosforinas